According to our (Global Info Research) latest study, the global Mycoplasma Rapid Detection Kit market size was valued at US$ 638 million in 2025 and is forecast to a readjusted size of US$ 1115 million by 2032 with a CAGR of 8.2% during review period.
Mycoplasma rapid detection kits are reagent sets used for rapid screening and quality control of Mycoplasma and other Mollicutes contamination in cell culture supernatants, media, cell bank samples, biopharmaceutical process samples, and cell therapy/ATMP samples. They are typically based on PCR/qPCR, LAMP isothermal amplification, ATP bioluminescence, digital PCR, or cell-based reporter assays, with fluorescent, colorimetric, luminescent, gel-band, or digital quantitative readouts that deliver results within minutes to hours. Key features include high sensitivity, simplified operation, strong tolerance to inhibitors, positive/negative and internal control systems, and support for pharmacopoeia-aligned validation and GMP quality control workflows, with overall gross margin about 62%.
Demand is mainly driven by biopharmaceutical manufacturing, vaccine and viral vector production, cell bank construction, cell therapy, and research cell culture workflows. As cell culture operations move toward higher throughput, multi-batch production, and commercial manufacturing, mycoplasma testing is shifting from occasional contamination investigation to routine batch quality control, with users prioritizing speed, sample compatibility, traceability, and alignment with release workflows.
Competition centers on detection principle, sensitivity, inhibitor tolerance, and validation documentation. qPCR and LAMP products are suitable for rapid screening and on-site interpretation, ATP bioluminescence products lower the operating barrier, while digital PCR and pharmacopoeia-validated qPCR products are better suited to high-value samples and regulated manufacturing. Product upgrades focus on one-tube premixes, lyophilized ambient shipping, direct sample input, contamination prevention systems, internal controls, and matched calibration materials.
European and U.S. suppliers have clear advantages in pharmacopoeia alignment, validation packages, and global customer coverage, while Chinese suppliers are gaining share through visual LAMP, PCR/qPCR rapid kits, and cost-responsive offerings. Opportunities lie in bundled supply of kits, reference standards, sample preparation, and method validation support; key risks include matrix inhibition, false-positive and false-negative control, different regulatory acceptance pathways, and management of the boundary between research-use and GMP-grade products.
Report Scope
This report is a detailed and comprehensive analysis for global Mycoplasma Rapid Detection Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Mycoplasma Rapid Detection Kit market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Mycoplasma Rapid Detection Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Mycoplasma Rapid Detection Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Mycoplasma Rapid Detection Kit market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mycoplasma Rapid Detection Kit
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mycoplasma Rapid Detection Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Thermo Fisher Scientific, Merck, Minerva Biolabs, Sartorius, Bio-Rad, ATCC, InvivoGen, Applied Biological Materials, MP Biomedicals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Mycoplasma Rapid Detection Kit market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
ATP Bioluminescence Kits
Conventional PCR Kits
Real-Time qPCR Kits
LAMP Isothermal Kits
Droplet Digital PCR Kits
Cell-Based Colorimetric Kits
Market segment by Readout Format
Gel Electrophoresis Readout
Fluorescent Probe Readout
Colorimetric Visual Readout
Luminescent Plate Reader Readout
Test Strip Readout
Digital Quantification Readout
Market segment by Sample Compatibility
Cell Culture Supernatant
Cell Culture Media and Serum
Cell Bank and Seed Train Samples
Biopharmaceutical Process Samples
ATMP and Cell Therapy Samples
Other Biological Matrices
Market segment by Validation Level
Research Use Routine Screening
QC Validated Screening
Pharmacopoeia-Aligned Testing
GMP/ATMP Process Release Support
Market segment by Application
Research Cell Culture Screening
Cell Bank Quality Control
Biologics Manufacturing QC
Vaccine and Viral Vector Production
Cell Therapy and ATMP Testing
Diagnostic Assay Development
Major players covered
Lonza
Thermo Fisher Scientific
Merck
Minerva Biolabs
Sartorius
Bio-Rad
ATCC
InvivoGen
Applied Biological Materials
MP Biomedicals
Norgen Biotek
Vazyme
Yeasen Biotechnology
TransGen Biotech
Arcegen
Beyotime Biotechnology
Ezassay Biotechnology
SouthernBiotech
GenHunter
Abcam
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Mycoplasma Rapid Detection Kit product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Mycoplasma Rapid Detection Kit, with price, sales quantity, revenue, and global market share of Mycoplasma Rapid Detection Kit from 2021 to 2026.
Chapter 3, the Mycoplasma Rapid Detection Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mycoplasma Rapid Detection Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Mycoplasma Rapid Detection Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Mycoplasma Rapid Detection Kit.
Chapter 14 and 15, to describe Mycoplasma Rapid Detection Kit sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Mycoplasma Rapid Detection Kit. Industry analysis & Market Report on Mycoplasma Rapid Detection Kit is a syndicated market report, published as Global Mycoplasma Rapid Detection Kit Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Mycoplasma Rapid Detection Kit market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.